Two cases of atypical bullous disease showing linear IgG and IgA deposition in the basement membrane zone. 1996

Y Kawahara, and T Hashimoto, and K Watanabe, and S Kurihara, and I Matsuo, and T Nishikawa
Department of Dermatology, Keio University School of Medicine, Tokyo, Japan.

Patients showing coexistent linear IgG and IgA deposition along the basement membrane zone on direct immunofluorescence have been described as either bullous pemphigoid, epidermolysis bullosa acquisita, linear IgA bullous dermatosis, or cicatricial pemphigoid, depending on the clinical features and laboratory findings. In the present report, we describe two cases showing atypical clinical features distinct from those of other known bullous diseases. No circulating antibodies were detected by indirect immunofluorescence of normal human skin. Indirect immunofluorescence of 1 M NaCl split skin revealed IgG and/or IgA antibodies reactive with the dermal side of the split. Immunoblotting of normal human epidermal and dermal extracts showed no apparent reactivity with known autoantigens. The results suggest that there may be a unique and distinct bullous disease with linear IgG and IgA deposition at the basement membrane zone.

UI MeSH Term Description Entries
D007070 Immunoglobulin A Represents 15-20% of the human serum immunoglobulins, mostly as the 4-chain polymer in humans or dimer in other mammals. Secretory IgA (IMMUNOGLOBULIN A, SECRETORY) is the main immunoglobulin in secretions. IgA,IgA Antibody,IgA1,IgA2,Antibody, IgA
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D008297 Male Males
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001485 Basement Membrane A darkly stained mat-like EXTRACELLULAR MATRIX (ECM) that separates cell layers, such as EPITHELIUM from ENDOTHELIUM or a layer of CONNECTIVE TISSUE. The ECM layer that supports an overlying EPITHELIUM or ENDOTHELIUM is called basal lamina. Basement membrane (BM) can be formed by the fusion of either two adjacent basal laminae or a basal lamina with an adjacent reticular lamina of connective tissue. BM, composed mainly of TYPE IV COLLAGEN; glycoprotein LAMININ; and PROTEOGLYCAN, provides barriers as well as channels between interacting cell layers. Basal Lamina,Basement Lamina,Lamina Densa,Lamina Lucida,Lamina Reticularis,Basement Membranes,Densas, Lamina,Lamina, Basal,Lamina, Basement,Lucida, Lamina,Membrane, Basement,Membranes, Basement,Reticularis, Lamina
D012867 Skin The outer covering of the body that protects it from the environment. It is composed of the DERMIS and the EPIDERMIS.
D012872 Skin Diseases, Vesiculobullous Skin diseases characterized by local or general distributions of blisters. They are classified according to the site and mode of blister formation. Lesions can appear spontaneously or be precipitated by infection, trauma, or sunlight. Etiologies include immunologic and genetic factors. (From Scientific American Medicine, 1990) Bullous Skin Diseases,Pustular Dermatosis, Subcorneal,Skin Diseases, Bullous,Skin Diseases, Vesicular,Sneddon-Wilkinson Disease,Subcorneal Pustular Dermatosis,Vesicular Skin Diseases,Vesiculobullous Skin Diseases,Bullous Dermatoses,Vesiculobullous Dermatoses,Bullous Skin Disease,Dermatoses, Bullous,Dermatoses, Subcorneal Pustular,Dermatoses, Vesiculobullous,Dermatosis, Subcorneal Pustular,Pustular Dermatoses, Subcorneal,Skin Disease, Bullous,Skin Disease, Vesicular,Skin Disease, Vesiculobullous,Sneddon Wilkinson Disease,Subcorneal Pustular Dermatoses,Vesicular Skin Disease,Vesiculobullous Skin Disease

Related Publications

Y Kawahara, and T Hashimoto, and K Watanabe, and S Kurihara, and I Matsuo, and T Nishikawa
March 1980, Clinical and experimental dermatology,
Y Kawahara, and T Hashimoto, and K Watanabe, and S Kurihara, and I Matsuo, and T Nishikawa
June 1981, Archives of dermatology,
Y Kawahara, and T Hashimoto, and K Watanabe, and S Kurihara, and I Matsuo, and T Nishikawa
May 1989, Journal of the American Academy of Dermatology,
Y Kawahara, and T Hashimoto, and K Watanabe, and S Kurihara, and I Matsuo, and T Nishikawa
July 2017, The British journal of dermatology,
Y Kawahara, and T Hashimoto, and K Watanabe, and S Kurihara, and I Matsuo, and T Nishikawa
June 1976, Archives of dermatology,
Y Kawahara, and T Hashimoto, and K Watanabe, and S Kurihara, and I Matsuo, and T Nishikawa
November 2013, JAMA dermatology,
Y Kawahara, and T Hashimoto, and K Watanabe, and S Kurihara, and I Matsuo, and T Nishikawa
May 2021, The Australasian journal of dermatology,
Y Kawahara, and T Hashimoto, and K Watanabe, and S Kurihara, and I Matsuo, and T Nishikawa
December 1995, Archives of dermatology,
Y Kawahara, and T Hashimoto, and K Watanabe, and S Kurihara, and I Matsuo, and T Nishikawa
February 1998, Journal of the American Academy of Dermatology,
Y Kawahara, and T Hashimoto, and K Watanabe, and S Kurihara, and I Matsuo, and T Nishikawa
May 2000, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete,
Copied contents to your clipboard!